Total Payments
$93,560
2024 Payments
$334.77
Companies
16
Transactions
119
Medicare Patients
1,379
Medicare Billing
$127,275
Payment Breakdown by Category
Other$52,590 (56.2%)
Consulting$26,628 (28.5%)
Travel$10,237 (10.9%)
Food & Beverage$3,938 (4.2%)
Education$126.20 (0.1%)
Research$41.10 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $28,950 | 8 | 30.9% |
| Consulting Fee | $26,628 | 13 | 28.5% |
| Honoraria | $23,640 | 13 | 25.3% |
| Travel and Lodging | $10,237 | 32 | 10.9% |
| Food and Beverage | $3,938 | 50 | 4.2% |
| Education | $126.20 | 2 | 0.1% |
| Unspecified | $41.10 | 1 | 0.0% |
Payments by Type
General
$93,519
118 transactions
Research
$41.10
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $44,387 | 36 | $0 (2022) |
| Adamas Pharmaceuticals, Inc. | $23,782 | 14 | $0 (2020) |
| ABBVIE INC. | $12,218 | 21 | $0 (2024) |
| Acorda Therapeutics, Inc | $2,825 | 1 | $0 (2020) |
| Amneal Pharmaceuticals LLC | $2,250 | 3 | $0 (2020) |
| MERZ NORTH AMERICA, INC. | $1,768 | 5 | $0 (2017) |
| Medtronic USA, Inc. | $1,599 | 9 | $0 (2020) |
| Boston Scientific Corporation | $1,135 | 4 | $0 (2019) |
| Abbott Laboratories | $1,118 | 10 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,012 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $334.77 | 3 | Microtransponder, Inc. ($185.34) |
| 2023 | $172.21 | 3 | Eisai Inc. ($121.96) |
| 2022 | $2,372 | 3 | ACADIA Pharmaceuticals Inc ($2,200) |
| 2021 | $9,728 | 9 | AbbVie Inc. ($8,948) |
| 2020 | $12,208 | 10 | Adamas Pharmaceuticals, Inc. ($5,440) |
| 2019 | $30,624 | 29 | ACADIA Pharmaceuticals Inc ($15,378) |
| 2018 | $32,584 | 39 | ACADIA Pharmaceuticals Inc ($25,355) |
| 2017 | $5,538 | 23 | AbbVie, Inc. ($3,095) |
All Payment Transactions
119 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $29.26 | General |
| Category: NEUROSCIENCE | ||||||
| 07/03/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $120.17 | General |
| Category: Neuromodulation | ||||||
| 01/24/2024 | Microtransponder, Inc. | — | Food and Beverage | Cash or cash equivalent | $185.34 | General |
| 08/18/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Central Nervous System | ||||||
| 04/22/2023 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $121.96 | General |
| Category: Neurology | ||||||
| 03/14/2023 | AbbVie Inc. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $34.79 | General |
| Category: NEUROSCIENCE | ||||||
| 11/17/2022 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $111.67 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2022 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $60.41 | General |
| Category: Neuromodulation | ||||||
| 03/21/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Consulting Fee | Cash or cash equivalent | $2,200.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/30/2021 | AbbVie Inc. | DUOPA (Drug) | Travel and Lodging | In-kind items and services | $378.40 | General |
| Category: NEUROSCIENCE | ||||||
| 11/24/2021 | AbbVie Inc. | DUOPA (Drug) | Travel and Lodging | In-kind items and services | $105.91 | General |
| Category: NEUROSCIENCE | ||||||
| 11/24/2021 | AbbVie Inc. | DUOPA (Drug) | Travel and Lodging | In-kind items and services | $46.46 | General |
| Category: NEUROSCIENCE | ||||||
| 11/24/2021 | AbbVie Inc. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2021 | AbbVie Inc. | DUOPA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,200.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2021 | AbbVie Inc. | DUOPA (Drug) | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/31/2021 | AbbVie Inc. | DUOPA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/17/2021 | AbbVie Inc. | DUOPA (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/26/2021 | Medtronic, Inc. | Percept (Device) | Consulting Fee | Cash or cash equivalent | $780.00 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 09/24/2020 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Consulting Fee | Cash or cash equivalent | $1,325.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 07/09/2020 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Honoraria | Cash or cash equivalent | $750.00 | General |
| Category: NEUROLOGY | ||||||
| 07/09/2020 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Honoraria | Cash or cash equivalent | $750.00 | General |
| Category: NEUROLOGY | ||||||
| 07/09/2020 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Honoraria | Cash or cash equivalent | $750.00 | General |
| Category: NEUROLOGY | ||||||
| 06/11/2020 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Consulting Fee | Cash or cash equivalent | $2,825.00 | General |
| Category: PARKINSONS DISEASE | ||||||
| 06/01/2020 | Adamas Pharmaceuticals, Inc. | GOCOVRI (Drug) | Honoraria | Cash or cash equivalent | $960.00 | General |
| Category: PD | ||||||
| 05/28/2020 | Adamas Pharmaceuticals, Inc. | GOCOVRI (Drug) | Honoraria | Cash or cash equivalent | $960.00 | General |
| Category: PD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 124 | 124 | $29,431 | $5,054 |
| 2021 | 17 | 732 | 1,187 | $336,145 | $80,730 |
| 2020 | 15 | 523 | 685 | $214,546 | $41,491 |
Total Patients
1,379
Total Services
1,996
Medicare Billing
$127,275
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 76 | 76 | $19,380 | $3,194 | 16.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 24 | 24 | $8,640 | $1,558 | 18.0% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Facility | 2022 | 24 | 24 | $1,411 | $301.59 | 21.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 184 | 238 | $85,680 | $24,251 | 28.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 105 | 105 | $52,500 | $13,335 | 25.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 133 | 150 | $38,250 | $9,652 | 25.2% |
| 64616 | Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | Facility | 2021 | 19 | 53 | $37,214 | $4,949 | 13.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 43 | 89 | $16,020 | $4,741 | 29.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 35 | 37 | $11,100 | $3,713 | 33.5% |
| 64642 | Injection of chemical for destruction of nerve muscles on one arm or leg, 1-4 muscles | Facility | 2021 | 20 | 51 | $22,384 | $3,660 | 16.3% |
| 95984 | Electronic analysis of implanted brain, spinal cord or peripheral stimulation device with brain stimulator programming, additional 15 minutes face-to-face time with qualified health care professional | Facility | 2021 | 16 | 91 | $9,646 | $3,004 | 31.1% |
| 64611 | Injection of chemical for destruction of salivary glands on both sides of the mouth | Facility | 2021 | 15 | 40 | $9,452 | $2,609 | 27.6% |
| 64643 | Injection of chemical for destruction of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Facility | 2021 | 17 | 50 | $14,440 | $2,485 | 17.2% |
| 64644 | Injection of chemical for destruction of nerve muscles on one arm or leg, 5 or more muscles | Facility | 2021 | 12 | 27 | $13,551 | $2,231 | 16.5% |
| 95874 | Needle measurement and recording of electrical activity of muscles for guidance with injection of chemical for destruction of muscles | Facility | 2021 | 44 | 111 | $6,644 | $1,661 | 25.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 24 | 47 | $6,110 | $1,379 | 22.6% |
| 95983 | Electronic analysis of implanted brain, spinal cord or peripheral stimulation device with brain stimulator programming, first 15 minutes face-to-face time with qualified health care professional | Facility | 2021 | 17 | 29 | $3,480 | $1,065 | 30.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 19 | 20 | $4,300 | $1,057 | 24.6% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2021 | 11 | 26 | $2,041 | $638.74 | 31.3% |
| 95970 | Electronic analysis of implanted brain, spinal cord or peripheral stimulation device | Facility | 2021 | 18 | 23 | $3,333 | $300.30 | 9.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 121 | 135 | $48,600 | $9,605 | 19.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 82 | 91 | $19,565 | $5,494 | 28.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 50 | 50 | $25,000 | $5,389 | 21.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 77 | 82 | $20,910 | $3,966 | 19.0% |
| 64616 | Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | Facility | 2020 | 19 | 44 | $31,200 | $3,951 | 12.7% |
About Dr. Danish Bhatti, MBBS
Dr. Danish Bhatti, MBBS is a Neurology healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/13/2008. The National Provider Identifier (NPI) number assigned to this provider is 1982858239.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Danish Bhatti, MBBS has received a total of $93,560 in payments from pharmaceutical and medical device companies, with $334.77 received in 2024. These payments were reported across 119 transactions from 16 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($28,950).
As a Medicare-enrolled provider, Bhatti has provided services to 1,379 Medicare beneficiaries, totaling 1,996 services with total Medicare billing of $127,275. Data is available for 3 years (2020–2022), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Student in an Organized Health Care Education/Training Program, Neurology
- Location Orlando, FL
- Active Since 11/13/2008
- Last Updated 06/06/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1982858239
Products in Payments
- NUPLAZID (Drug) $44,387
- GOCOVRI (Drug) $23,782
- DUOPA (Drug) $9,094
- Duopa (Drug) $3,054
- INBRIJA (Drug) $2,825
- RYTARY (Drug) $2,250
- ACTIVA (Device) $1,599
- GENERAL DBS (Device) $1,073
- AUSTEDO (Drug) $901.87
- Infinity DBS Pulse Generators (Device) $813.42
- Percept (Device) $780.00
- BOTOX (Biological) $278.14
- Xeomin (Biological) $184.90
- INFINITY (Device) $180.58
- Proclaim Family of SCS IPGs (Device) $123.73
- Leqembi (Drug) $121.96
- VERCISE (Device) $62.44
- NORTHERA (Drug) $60.25
- VYALEV (Drug) $29.26
- SD809-HD (Drug) $18.12
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Orlando
Dr. Ramon Rodriguez-Cruz, Md, MD
Neurology — Payments: $1.6M
Neurology $1.6M
Amparo Gutierrez, Md, MD
Neurology — Payments: $785,842
Neurology $785,842
Mark Klafter, D.o, D.O
Neurology — Payments: $272,905
Neurology $272,905
Dr. Nicholas Avgeropoulos, Md, MD
Neurology — Payments: $161,837
Neurology $161,837
Dr. Herbert Newton, M.d, M.D
Neurology — Payments: $105,226
Neurology $105,226
Fernando Gonzales-Portillo, Md, MD
Neurology — Payments: $42,248
Neurology $42,248